UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

British journal of cancer, 2010-08, Vol.103 (5), p.668-675

2010

Volltextzugriff (PDF)

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

British journal of cancer, 2015-03, Vol.112 (7), p.1215-1222

2015

Volltextzugriff (PDF)

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

British journal of cancer, 2015-12, Vol.113 (12), p.1746-1746

2015

Volltextzugriff (PDF)

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort

NPJ breast cancer, 2018-03, Vol.4 (1), p.5-9, Article 5

2018

Volltextzugriff (PDF)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

British journal of cancer, 2010-09, Vol.103 (7), p.1137-1137

2010

Volltextzugriff (PDF)

OncotypeDX Risk Stratification in Early Stage Breast Cancer: When is Accelerated Partial Breast Irradiation (APBI) Safe?

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e591-e591

2018

Volltextzugriff (PDF)

Immunohistochemical expression of BRCA1 protein in invasive ductal carcinoma of the breast

Georgian medical news, 2010-07 (184-185), p.51-60

2010

Volltextzugriff (PDF)

Sentinel lymph node biopsy versus lymphadenectomy for high-grade endometrial cancer staging (SENTOR trial): A prospective multicenter cohort study

Gynecologic oncology, 2020-10, Vol.159, p.2-2

2020

Volltextzugriff (PDF)

Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer

Ceskoslovenské patologie, 2007-07, Vol.43 (3), p.87-92

2007

Volltextzugriff (PDF)

7 Sentinel lymph node biopsy versus lymphadenectomy for intermediate and high grade endometrial cancer staging (SENTOR trial): a prospective multicenter cohort study

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A5-A5

2020

Volltextzugriff (PDF)

Mammary gland development and cancer

Ceskoslovenské patologie, 2005-07, Vol.41 (3), p.94-101

2005

Volltextzugriff (PDF)

Erratum: A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

British journal of cancer, 2015-12, Vol.113 (12), p.1746-1746

2015

Volltextzugriff (PDF)

Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade

Georgian medical news, 2006-03 (132), p.24-27

2006

Volltextzugriff (PDF)

The expression of cadherin e and clinical prognostic factors in uterine endometrioid adenocarcinoma

Georgian medical news, 2005-11 (128), p.17

2005

Volltextzugriff (PDF)

Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma

Georgian medical news, 2005-09 (126), p.27-31

2005

Volltextzugriff (PDF)

P-433 The cytological differential diagnostic algorithm for reactive mesothelium, epithelial mesothelioma and metastatic adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S230-S230

2005

Volltextzugriff (PDF)

Evaluation of PTEN, EGFR, and Ki67 expression as predictors of response to a trastuzumab-containing neoadjuvant chemotherapy regimen in a HER2 overexpressing locally advanced breast cancer (LABC) trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11029-e11029

2011

Volltextzugriff (PDF)

P1-12-25: Evaluation of PTEN, EGFR and Ki67 Expression as Predictors of Response to a Trastuzumab-Containing Neoadjuvant Chemotherapy Regimen in a HER-2 Over-Expressing Locally Advanced Breast Cancer (LABC) Trial

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-12-25

2011

Volltextzugriff (PDF)

Evaluation of HER-2/neu expression in clinically localized prostate cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4768-4768

2005

Volltextzugriff (PDF)

0612: The Prognosis of Uterine Endometrioid Carcinoma By Immunohistochemical Expression of Cathe-Psin D and E Cadherin

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.771-772

2006

Volltextzugriff (PDF)

Comparative study of immunohistochemical phenotype in primary breast cancer tissues and lymph node metastases

European journal of cancer supplements, 2006-03, Vol.4 (2), p.123-123

2006

Volltextzugriff (PDF)

P-651 Combined use of bronchial lavages and brushings in diagnosis and typing of central lung tumors

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S289-S290

2005

Volltextzugriff (PDF)

Erratum: BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

British journal of cancer, 2010-09, Vol.103 (7), p.1137-1137

2010

Volltextzugriff (PDF)

Evaluation of histological regression after neoadjuvant CAF chemotherapy in p53-positive and p53-negative invasive breast carcinomas of reproductive and postmenopausal women

European journal of cancer supplements, 2004-03, Vol.2 (3), p.175-175

2004

Volltextzugriff (PDF)

AgNOR counts and characteristics of a sex chromatin distribution in ductal intraepithelial neoplasias of the breast

European journal of cancer supplements, 2004-03, Vol.2 (3), p.175-176

2004

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

OncotypeDX Risk Stratification in Early Stage Breast Cancer: When is Accelerated Partial Breast Irradiation (APBI) Safe?

Immunohistochemical expression of BRCA1 protein in invasive ductal carcinoma of the breast

Sentinel lymph node biopsy versus lymphadenectomy for high-grade endometrial cancer staging (SENTOR trial): A prospective multicenter cohort study

Expression of E-cadherin and c-erbB-2/HER-2/neu oncoprotein in high-grade breast cancer

7 Sentinel lymph node biopsy versus lymphadenectomy for intermediate and high grade endometrial cancer staging (SENTOR trial): a prospective multicenter cohort study

Mammary gland development and cancer

Erratum: A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer

Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade

The expression of cadherin e and clinical prognostic factors in uterine endometrioid adenocarcinoma

Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma

P-433 The cytological differential diagnostic algorithm for reactive mesothelium, epithelial mesothelioma and metastatic adenocarcinoma

Evaluation of PTEN, EGFR, and Ki67 expression as predictors of response to a trastuzumab-containing neoadjuvant chemotherapy regimen in a HER2 overexpressing locally advanced breast cancer (LABC) trial

P1-12-25: Evaluation of PTEN, EGFR and Ki67 Expression as Predictors of Response to a Trastuzumab-Containing Neoadjuvant Chemotherapy Regimen in a HER-2 Over-Expressing Locally Advanced Breast Cancer (LABC) Trial

Evaluation of HER-2/neu expression in clinically localized prostate cancer

0612: The Prognosis of Uterine Endometrioid Carcinoma By Immunohistochemical Expression of Cathe-Psin D and E Cadherin

Comparative study of immunohistochemical phenotype in primary breast cancer tissues and lymph node metastases

P-651 Combined use of bronchial lavages and brushings in diagnosis and typing of central lung tumors

Erratum: BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Evaluation of histological regression after neoadjuvant CAF chemotherapy in p53-positive and p53-negative invasive breast carcinomas of reproductive and postmenopausal women

AgNOR counts and characteristics of a sex chromatin distribution in ductal intraepithelial neoplasias of the breast

Suchergebnisse filtern